Latest Content

FDA Approves Avmapki Fakzynja Co-pack for KRAS Serous Ovarian Cancer

May 8th 2025, 4:46pm

By Spencer Feldman

Article

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian cancer with KRAS mutations.

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

May 8th 2025, 3:00pm

By Spencer Feldman

Article

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.

Navigating Lymphoma and Survivorship in Adolescents and Young Adults

May 8th 2025, 1:00pm

By Ryan Scott

Article

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their diagnosis.

Managing Elacestrant Treatment: From Patient Selection to Supportive Care

May 8th 2025, 12:05pm

By Virginia Kaklamani, MD, DSc

Video

Panelists discuss balancing clinical trial data with real-world patient factors when choosing between treatment options, emphasizing the importance of quality of life alongside cancer control in the second-line setting.

EMERALD Trial Results: What Prior CDK4/6i Duration Means for Treatment Success

May 8th 2025, 12:00pm

By Virginia Kaklamani, MD, DSc

Video

Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its FDA approval for this specific population.

Honoring a Healer: Personal Care With National Impact

May 7th 2025, 9:00pm

By Dr. Estelamari Rodriguez

Article

This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez.

Managing Lung Inflammation After Chemoradiation and Tagrisso

May 7th 2025, 8:00pm

By Dr. Suresh S. Ramalingam

Article

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.

How Quitting Smoking After a Cancer Diagnosis Can Boost Survival

May 7th 2025, 7:00pm

By Ryan Scott

Article

Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.

A Nurse Who Became Family After a Cancer Diagnosis

May 7th 2025, 5:00pm

By Kim Johnson

Article

Eric Z. cared for my sister and mentored me with compassion, wisdom and unwavering presence — shaping my path in nursing and life.

Cemsidomide Generates Results at Multiple Doses in Multiple Myeloma

May 7th 2025, 4:00pm

By Ryan Scott

Article

Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma

Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer

May 7th 2025, 3:00pm

By Spencer Feldman

Article

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer.

Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions

May 7th 2025, 1:00pm

By Connie Pombo

Article

After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure.

Fighting for Patients, Processes and Education

May 6th 2025, 9:00pm

By Dr. Theresa Medina

Article

I would like to nominate Ashley Tullio, RN, for the Extraordinary Healer Award for Oncology Nursing.

Immune Therapy Expands Melanoma Treatment to More Patients

May 6th 2025, 8:00pm

By Dr. Douglas B. Johnson

Video

Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment.

The Importance of Personalized Treatment Approaches for Urologic Cancers

May 6th 2025, 7:00pm

By Ryan Scott

Article

Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such as bladder or kidney cancer.